Global Anti-Malarial Drug Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028
The Anti-Malarial Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Anti-Malarial Drug market size is estimated to be worth US$ 702.3 million in 2021 and is forecast to a readjusted size of USD 833.7 million by 2028 with a CAGR of 2.5% during review period. Hospital Pharmacy accounting for % of the Anti-Malarial Drug global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Plasmodium Falciparum segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Anti-Malarial Drug include GlaxoSmithKline, Ranbaxy, Zydus Cadila, Alvizia, and Bayer, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Anti-Malarial Drug market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Plasmodium Falciparum
Plasmodium Vivax
Plasmodium Malariae
Plasmodium Ovale
Market segment by Application can be divided into
Hospital Pharmacy
Retail Pharmacy
E-Commerce
Others
The key market players for global Anti-Malarial Drug market are listed below:
GlaxoSmithKline
Ranbaxy
Zydus Cadila
Alvizia
Bayer
Ipca
Merck
F. Hoffmann-La Roche
Novartis
Pfizer
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-Malarial Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anti-Malarial Drug, with price, sales, revenue and global market share of Anti-Malarial Drug from 2019 to 2022.
Chapter 3, the Anti-Malarial Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-Malarial Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Anti-Malarial Drug market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Anti-Malarial Drug.
Chapter 13, 14, and 15, to describe Anti-Malarial Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Frequently Asked Questions
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
- By Type
- By Application
- By Region
- By Country
- By Manufacturer
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Anti-Malarial Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti-Malarial Drug Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Plasmodium Falciparum
1.2.3 Plasmodium Vivax
1.2.4 Plasmodium Malariae
1.2.5 Plasmodium Ovale
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti-Malarial Drug Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 E-Commerce
1.3.5 Others
1.4 Global Anti-Malarial Drug Market Size & Forecast
1.4.1 Global Anti-Malarial Drug Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Anti-Malarial Drug Sales in Volume (2017-2028)
1.4.3 Global Anti-Malarial Drug Price (2017-2028)
1.5 Global Anti-Malarial Drug Production Capacity Analysis
1.5.1 Global Anti-Malarial Drug Total Production Capacity (2017-2028)
1.5.2 Global Anti-Malarial Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anti-Malarial Drug Market Drivers
1.6.2 Anti-Malarial Drug Market Restraints
1.6.3 Anti-Malarial Drug Trends Analysis
2 Manufacturers Profiles
2.1 GlaxoSmithKline
2.1.1 GlaxoSmithKline Details
2.1.2 GlaxoSmithKline Major Business
2.1.3 GlaxoSmithKline Anti-Malarial Drug Product and Services
2.1.4 GlaxoSmithKline Anti-Malarial Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Ranbaxy
2.2.1 Ranbaxy Details
2.2.2 Ranbaxy Major Business
2.2.3 Ranbaxy Anti-Malarial Drug Product and Services
2.2.4 Ranbaxy Anti-Malarial Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Zydus Cadila
2.3.1 Zydus Cadila Details
2.3.2 Zydus Cadila Major Business
2.3.3 Zydus Cadila Anti-Malarial Drug Product and Services
2.3.4 Zydus Cadila Anti-Malarial Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Alvizia
2.4.1 Alvizia Details
2.4.2 Alvizia Major Business
2.4.3 Alvizia Anti-Malarial Drug Product and Services
2.4.4 Alvizia Anti-Malarial Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Bayer
2.5.1 Bayer Details
2.5.2 Bayer Major Business
2.5.3 Bayer Anti-Malarial Drug Product and Services
2.5.4 Bayer Anti-Malarial Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Ipca
2.6.1 Ipca Details
2.6.2 Ipca Major Business
2.6.3 Ipca Anti-Malarial Drug Product and Services
2.6.4 Ipca Anti-Malarial Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Merck
2.7.1 Merck Details
2.7.2 Merck Major Business
2.7.3 Merck Anti-Malarial Drug Product and Services
2.7.4 Merck Anti-Malarial Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 F. Hoffmann-La Roche
2.8.1 F. Hoffmann-La Roche Details
2.8.2 F. Hoffmann-La Roche Major Business
2.8.3 F. Hoffmann-La Roche Anti-Malarial Drug Product and Services
2.8.4 F. Hoffmann-La Roche Anti-Malarial Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Novartis
2.9.1 Novartis Details
2.9.2 Novartis Major Business
2.9.3 Novartis Anti-Malarial Drug Product and Services
2.9.4 Novartis Anti-Malarial Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Pfizer
2.10.1 Pfizer Details
2.10.2 Pfizer Major Business
2.10.3 Pfizer Anti-Malarial Drug Product and Services
2.10.4 Pfizer Anti-Malarial Drug Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Anti-Malarial Drug Breakdown Data by Manufacturer
3.1 Global Anti-Malarial Drug Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Anti-Malarial Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Anti-Malarial Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Anti-Malarial Drug Manufacturer Market Share in 2021
3.4.2 Top 6 Anti-Malarial Drug Manufacturer Market Share in 2021
3.5 Global Anti-Malarial Drug Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Anti-Malarial Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anti-Malarial Drug Market Size by Region
4.1.1 Global Anti-Malarial Drug Sales in Volume by Region (2017-2028)
4.1.2 Global Anti-Malarial Drug Revenue by Region (2017-2028)
4.2 North America Anti-Malarial Drug Revenue (2017-2028)
4.3 Europe Anti-Malarial Drug Revenue (2017-2028)
4.4 Asia-Pacific Anti-Malarial Drug Revenue (2017-2028)
4.5 South America Anti-Malarial Drug Revenue (2017-2028)
4.6 Middle East and Africa Anti-Malarial Drug Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Anti-Malarial Drug Sales in Volume by Type (2017-2028)
5.2 Global Anti-Malarial Drug Revenue by Type (2017-2028)
5.3 Global Anti-Malarial Drug Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Anti-Malarial Drug Sales in Volume by Application (2017-2028)
6.2 Global Anti-Malarial Drug Revenue by Application (2017-2028)
6.3 Global Anti-Malarial Drug Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Anti-Malarial Drug Sales by Type (2017-2028)
7.2 North America Anti-Malarial Drug Sales by Application (2017-2028)
7.3 North America Anti-Malarial Drug Market Size by Country
7.3.1 North America Anti-Malarial Drug Sales in Volume by Country (2017-2028)
7.3.2 North America Anti-Malarial Drug Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Anti-Malarial Drug Sales by Type (2017-2028)
8.2 Europe Anti-Malarial Drug Sales by Application (2017-2028)
8.3 Europe Anti-Malarial Drug Market Size by Country
8.3.1 Europe Anti-Malarial Drug Sales in Volume by Country (2017-2028)
8.3.2 Europe Anti-Malarial Drug Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Anti-Malarial Drug Sales by Type (2017-2028)
9.2 Asia-Pacific Anti-Malarial Drug Sales by Application (2017-2028)
9.3 Asia-Pacific Anti-Malarial Drug Market Size by Region
9.3.1 Asia-Pacific Anti-Malarial Drug Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Anti-Malarial Drug Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Anti-Malarial Drug Sales by Type (2017-2028)
10.2 South America Anti-Malarial Drug Sales by Application (2017-2028)
10.3 South America Anti-Malarial Drug Market Size by Country
10.3.1 South America Anti-Malarial Drug Sales in Volume by Country (2017-2028)
10.3.2 South America Anti-Malarial Drug Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anti-Malarial Drug Sales by Type (2017-2028)
11.2 Middle East & Africa Anti-Malarial Drug Sales by Application (2017-2028)
11.3 Middle East & Africa Anti-Malarial Drug Market Size by Country
11.3.1 Middle East & Africa Anti-Malarial Drug Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Anti-Malarial Drug Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Anti-Malarial Drug and Key Manufacturers
12.2 Manufacturing Costs Percentage of Anti-Malarial Drug
12.3 Anti-Malarial Drug Production Process
12.4 Anti-Malarial Drug Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Anti-Malarial Drug Typical Distributors
13.3 Anti-Malarial Drug Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Anti-Malarial Drug Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Anti-Malarial Drug Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 4. GlaxoSmithKline Major Business
Table 5. GlaxoSmithKline Anti-Malarial Drug Product and Services
Table 6. GlaxoSmithKline Anti-Malarial Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Ranbaxy Basic Information, Manufacturing Base and Competitors
Table 8. Ranbaxy Major Business
Table 9. Ranbaxy Anti-Malarial Drug Product and Services
Table 10. Ranbaxy Anti-Malarial Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 12. Zydus Cadila Major Business
Table 13. Zydus Cadila Anti-Malarial Drug Product and Services
Table 14. Zydus Cadila Anti-Malarial Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Alvizia Basic Information, Manufacturing Base and Competitors
Table 16. Alvizia Major Business
Table 17. Alvizia Anti-Malarial Drug Product and Services
Table 18. Alvizia Anti-Malarial Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Bayer Basic Information, Manufacturing Base and Competitors
Table 20. Bayer Major Business
Table 21. Bayer Anti-Malarial Drug Product and Services
Table 22. Bayer Anti-Malarial Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Ipca Basic Information, Manufacturing Base and Competitors
Table 24. Ipca Major Business
Table 25. Ipca Anti-Malarial Drug Product and Services
Table 26. Ipca Anti-Malarial Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Merck Basic Information, Manufacturing Base and Competitors
Table 28. Merck Major Business
Table 29. Merck Anti-Malarial Drug Product and Services
Table 30. Merck Anti-Malarial Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 32. F. Hoffmann-La Roche Major Business
Table 33. F. Hoffmann-La Roche Anti-Malarial Drug Product and Services
Table 34. F. Hoffmann-La Roche Anti-Malarial Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Novartis Basic Information, Manufacturing Base and Competitors
Table 36. Novartis Major Business
Table 37. Novartis Anti-Malarial Drug Product and Services
Table 38. Novartis Anti-Malarial Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Pfizer Basic Information, Manufacturing Base and Competitors
Table 40. Pfizer Major Business
Table 41. Pfizer Anti-Malarial Drug Product and Services
Table 42. Pfizer Anti-Malarial Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Anti-Malarial Drug Sales by Manufacturer (2019, 2020, 2021, and 2022) & (MT)
Table 44. Global Anti-Malarial Drug Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Anti-Malarial Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Anti-Malarial Drug Production Capacity by Company, (MT): 2020 VS 2021
Table 47. Head Office and Anti-Malarial Drug Production Site of Key Manufacturer
Table 48. Anti-Malarial Drug New Entrant and Capacity Expansion Plans
Table 49. Anti-Malarial Drug Mergers & Acquisitions in the Past Five Years
Table 50. Global Anti-Malarial Drug Sales by Region (2017-2022) & (MT)
Table 51. Global Anti-Malarial Drug Sales by Region (2023-2028) & (MT)
Table 52. Global Anti-Malarial Drug Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Anti-Malarial Drug Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Anti-Malarial Drug Sales by Type (2017-2022) & (MT)
Table 55. Global Anti-Malarial Drug Sales by Type (2023-2028) & (MT)
Table 56. Global Anti-Malarial Drug Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Anti-Malarial Drug Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Anti-Malarial Drug Price by Type (2017-2022) & (USD/Kg)
Table 59. Global Anti-Malarial Drug Price by Type (2023-2028) & (USD/Kg)
Table 60. Global Anti-Malarial Drug Sales by Application (2017-2022) & (MT)
Table 61. Global Anti-Malarial Drug Sales by Application (2023-2028) & (MT)
Table 62. Global Anti-Malarial Drug Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Anti-Malarial Drug Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Anti-Malarial Drug Price by Application (2017-2022) & (USD/Kg)
Table 65. Global Anti-Malarial Drug Price by Application (2023-2028) & (USD/Kg)
Table 66. North America Anti-Malarial Drug Sales by Country (2017-2022) & (MT)
Table 67. North America Anti-Malarial Drug Sales by Country (2023-2028) & (MT)
Table 68. North America Anti-Malarial Drug Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Anti-Malarial Drug Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Anti-Malarial Drug Sales by Type (2017-2022) & (MT)
Table 71. North America Anti-Malarial Drug Sales by Type (2023-2028) & (MT)
Table 72. North America Anti-Malarial Drug Sales by Application (2017-2022) & (MT)
Table 73. North America Anti-Malarial Drug Sales by Application (2023-2028) & (MT)
Table 74. Europe Anti-Malarial Drug Sales by Country (2017-2022) & (MT)
Table 75. Europe Anti-Malarial Drug Sales by Country (2023-2028) & (MT)
Table 76. Europe Anti-Malarial Drug Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Anti-Malarial Drug Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Anti-Malarial Drug Sales by Type (2017-2022) & (MT)
Table 79. Europe Anti-Malarial Drug Sales by Type (2023-2028) & (MT)
Table 80. Europe Anti-Malarial Drug Sales by Application (2017-2022) & (MT)
Table 81. Europe Anti-Malarial Drug Sales by Application (2023-2028) & (MT)
Table 82. Asia-Pacific Anti-Malarial Drug Sales by Region (2017-2022) & (MT)
Table 83. Asia-Pacific Anti-Malarial Drug Sales by Region (2023-2028) & (MT)
Table 84. Asia-Pacific Anti-Malarial Drug Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Anti-Malarial Drug Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Anti-Malarial Drug Sales by Type (2017-2022) & (MT)
Table 87. Asia-Pacific Anti-Malarial Drug Sales by Type (2023-2028) & (MT)
Table 88. Asia-Pacific Anti-Malarial Drug Sales by Application (2017-2022) & (MT)
Table 89. Asia-Pacific Anti-Malarial Drug Sales by Application (2023-2028) & (MT)
Table 90. South America Anti-Malarial Drug Sales by Country (2017-2022) & (MT)
Table 91. South America Anti-Malarial Drug Sales by Country (2023-2028) & (MT)
Table 92. South America Anti-Malarial Drug Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Anti-Malarial Drug Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Anti-Malarial Drug Sales by Type (2017-2022) & (MT)
Table 95. South America Anti-Malarial Drug Sales by Type (2023-2028) & (MT)
Table 96. South America Anti-Malarial Drug Sales by Application (2017-2022) & (MT)
Table 97. South America Anti-Malarial Drug Sales by Application (2023-2028) & (MT)
Table 98. Middle East & Africa Anti-Malarial Drug Sales by Region (2017-2022) & (MT)
Table 99. Middle East & Africa Anti-Malarial Drug Sales by Region (2023-2028) & (MT)
Table 100. Middle East & Africa Anti-Malarial Drug Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Anti-Malarial Drug Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Anti-Malarial Drug Sales by Type (2017-2022) & (MT)
Table 103. Middle East & Africa Anti-Malarial Drug Sales by Type (2023-2028) & (MT)
Table 104. Middle East & Africa Anti-Malarial Drug Sales by Application (2017-2022) & (MT)
Table 105. Middle East & Africa Anti-Malarial Drug Sales by Application (2023-2028) & (MT)
Table 106. Anti-Malarial Drug Raw Material
Table 107. Key Manufacturers of Anti-Malarial Drug Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Anti-Malarial Drug Typical Distributors
Table 111. Anti-Malarial Drug Typical Customers
List of Figures
Figure 1. Anti-Malarial Drug Picture
Figure 2. Global Anti-Malarial Drug Revenue Market Share by Type in 2021
Figure 3. Plasmodium Falciparum
Figure 4. Plasmodium Vivax
Figure 5. Plasmodium Malariae
Figure 6. Plasmodium Ovale
Figure 7. Global Anti-Malarial Drug Revenue Market Share by Application in 2021
Figure 8. Hospital Pharmacy
Figure 9. Retail Pharmacy
Figure 10. E-Commerce
Figure 11. Others
Figure 12. Global Anti-Malarial Drug Revenue, (USD Million) & (MT): 2017 & 2021 & 2028
Figure 13. Global Anti-Malarial Drug Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Anti-Malarial Drug Sales (2017-2028) & (MT)
Figure 15. Global Anti-Malarial Drug Price (2017-2028) & (USD/Kg)
Figure 16. Global Anti-Malarial Drug Production Capacity (2017-2028) & (MT)
Figure 17. Global Anti-Malarial Drug Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Anti-Malarial Drug Market Drivers
Figure 19. Anti-Malarial Drug Market Restraints
Figure 20. Anti-Malarial Drug Market Trends
Figure 21. Global Anti-Malarial Drug Sales Market Share by Manufacturer in 2021
Figure 22. Global Anti-Malarial Drug Revenue Market Share by Manufacturer in 2021
Figure 23. Anti-Malarial Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Anti-Malarial Drug Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Anti-Malarial Drug Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Anti-Malarial Drug Sales Market Share by Region (2017-2028)
Figure 27. Global Anti-Malarial Drug Revenue Market Share by Region (2017-2028)
Figure 28. North America Anti-Malarial Drug Revenue (2017-2028) & (USD Million)
Figure 29. Europe Anti-Malarial Drug Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Anti-Malarial Drug Revenue (2017-2028) & (USD Million)
Figure 31. South America Anti-Malarial Drug Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Anti-Malarial Drug Revenue (2017-2028) & (USD Million)
Figure 33. Global Anti-Malarial Drug Sales Market Share by Type (2017-2028)
Figure 34. Global Anti-Malarial Drug Revenue Market Share by Type (2017-2028)
Figure 35. Global Anti-Malarial Drug Price by Type (2017-2028) & (USD/Kg)
Figure 36. Global Anti-Malarial Drug Sales Market Share by Application (2017-2028)
Figure 37. Global Anti-Malarial Drug Revenue Market Share by Application (2017-2028)
Figure 38. Global Anti-Malarial Drug Price by Application (2017-2028) & (USD/Kg)
Figure 39. North America Anti-Malarial Drug Sales Market Share by Type (2017-2028)
Figure 40. North America Anti-Malarial Drug Sales Market Share by Application (2017-2028)
Figure 41. North America Anti-Malarial Drug Sales Market Share by Country (2017-2028)
Figure 42. North America Anti-Malarial Drug Revenue Market Share by Country (2017-2028)
Figure 43. United States Anti-Malarial Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Anti-Malarial Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Anti-Malarial Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Anti-Malarial Drug Sales Market Share by Type (2017-2028)
Figure 47. Europe Anti-Malarial Drug Sales Market Share by Application (2017-2028)
Figure 48. Europe Anti-Malarial Drug Sales Market Share by Country (2017-2028)
Figure 49. Europe Anti-Malarial Drug Revenue Market Share by Country (2017-2028)
Figure 50. Germany Anti-Malarial Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Anti-Malarial Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Anti-Malarial Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Anti-Malarial Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Anti-Malarial Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Anti-Malarial Drug Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Anti-Malarial Drug Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Anti-Malarial Drug Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Anti-Malarial Drug Revenue Market Share by Region (2017-2028)
Figure 59. China Anti-Malarial Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Anti-Malarial Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Anti-Malarial Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Anti-Malarial Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Anti-Malarial Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Anti-Malarial Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Anti-Malarial Drug Sales Market Share by Type (2017-2028)
Figure 66. South America Anti-Malarial Drug Sales Market Share by Application (2017-2028)
Figure 67. South America Anti-Malarial Drug Sales Market Share by Country (2017-2028)
Figure 68. South America Anti-Malarial Drug Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Anti-Malarial Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Anti-Malarial Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Anti-Malarial Drug Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Anti-Malarial Drug Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Anti-Malarial Drug Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Anti-Malarial Drug Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Anti-Malarial Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Anti-Malarial Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Anti-Malarial Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Anti-Malarial Drug Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Anti-Malarial Drug in 2021
Figure 80. Manufacturing Process Analysis of Anti-Malarial Drug
Figure 81. Anti-Malarial Drug Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source
